Evidence map›Paper›PMID 36512509›Full record

ArticleJournal of natural products2022

Dactylosporolides: Glycosylated Macrolides from

Thibault Caradec, Xavier Trivelli, Eva Desmecht, Veronique Peucelle, Jamal Khalife, Ruben C Hartkoorn

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of natural products, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Thibault CaradecUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019─UMR 9017─CIIL─Center for Infection and Immunity of Lille, F-59000 Lille, France.ORCID 0000-0002-4461-654X
Xavier TrivelliUniv. Lille, CNRS, INRAE, Centrale Lille, Univ. Artois, FR 2638─IMEC─Institut Michel-Eugène Chevreul, Lille 59000, France.ORCID 0000-0001-6775-9650
Eva DesmechtUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019─UMR 9017─CIIL─Center for Infection and Immunity of Lille, F-59000 Lille, France.
Veronique PeucelleUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019─UMR 9017─CIIL─Center for Infection and Immunity of Lille, F-59000 Lille, France.
Jamal KhalifeUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019─UMR 9017─CIIL─Center for Infection and Immunity of Lille, F-59000 Lille, France.
Ruben C HartkoornUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019─UMR 9017─CIIL─Center for Infection and Immunity of Lille, F-59000 Lille, France.ORCID 0000-0001-7315-1553
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of novel macrolides were discovered from the culture supernatant of the rare soil actinobacteria

Indexed as

ActinobacteriaMicromonosporaceaeAnti-Bacterial AgentsGlycosylationMacrolidesAnti-Bacterial AgentsMacrolides

Identifiers

PMID36512509
PMCPMC9791991
OpenAlexW4311258371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.